CIAM
STOK icon

Caitong International Asset Management’s Stoke Therapeutics STOK Stock Holding History

Caitong International Asset Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589 Sell
18
-5,644
-100% -$181K ﹤0.01% 1682
2026
Q1 		$184K Buy
+5,662
New +$186K 0.03% 409
2025
Q3 		– Sell
-274
Closed -$3.11K – 2484
2025
Q2 		$3.11K Buy
+274
New +$2.6K ﹤0.01% 1222
2025
Q1 		– Sell
-59
Closed -$651 – 2513
2024
Q4 		$651 Buy
+59
New +$725 ﹤0.01% 1414

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Caitong International Asset Management's STOK Position: Q2 2026 in Review

Caitong International Asset Management reduced its Stoke Therapeutics (STOK) stake by 100% in Q2 2026, selling an estimated $181K and leaving 18 shares worth $589. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

Caitong International Asset Management first reported a position in STOK in Q4 2024 and has held it in 4 quarters since. The position peaked at $184K in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Caitong International Asset Management held 18 shares of Stoke Therapeutics worth $589 as of Q2 2026.
  • Caitong International Asset Management sold 5,644 Stoke Therapeutics shares in Q2 2026, an estimated $181K.
  • Stoke Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1682 holding.
  • Caitong International Asset Management first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's Stoke Therapeutics position peaked at $184K in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.